Jennerex Biotherapeutics Obtains $21,600,000 New Round

  • Feed Type
  • Date
    5/23/2013
  • Company Name
    Jennerex Biotherapeutics
  • Mailing Address
    450 Sansome St 16th Floor San Francisco, CA 94111
  • Company Description
    Jennerex Biotherapeutics, Inc. is a biotechnology company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors.
  • Website
    http://www.jennerex.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This financing will enable us to expand our efforts to develop Pexa-Vec as a novel therapeutic option for liver cancer, our lead program, which represents the third most deadly cancer in the world.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.